+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Marijuana - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309784
The global market for Medical Marijuana is estimated at US$32.3 Billion in 2023 and is projected to reach US$82.5 Billion by 2030, growing at a CAGR of 14.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Extract Form Marijuana segment, which is expected to reach US$54.2 Billion by 2030 with a CAGR of 14.6%. The Dried Flower Marijuana segment is also set to grow at 13.7% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $9.9 Billion in 2023, and China, forecasted to grow at an impressive 13.6% CAGR to reach $14.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Medical Marijuana Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Medical Marijuana Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Medical Marijuana Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as ABcann Medicinals, Inc., Aphria, Inc., Aurora Cannabis, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 44 Featured):

  • ABcann Medicinals, Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corporation
  • Emerald Health Therapeutics Inc.
  • Green Relief Inc.
  • GW Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Maricann Group, Inc.
  • mCig, Inc.
  • Medical Marijuana, Inc.
  • The Cronos Group Inc.
  • The Supreme Cannabis Company
  • Tilray
  • United Cannabis

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Medical Marijuana - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Medical Marijuana Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 6: World Recent Past, Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Extract Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Extract Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Dried Flower by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Dried Flower by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Seizures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Seizures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 15: USA 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 16: USA Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 17: USA 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
CANADA
  • Table 18: Canada Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 19: Canada 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 20: Canada Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: Canada 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
JAPAN
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 22: Japan Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 23: Japan 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 24: Japan Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 25: Japan 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
CHINA
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: China 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 28: China Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: China 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
EUROPE
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 30: Europe Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Europe 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Medical Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 33: Europe 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 34: Europe Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Europe 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
FRANCE
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 36: France Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: France 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 38: France Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: France 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
GERMANY
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 40: Germany Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: Germany 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 42: Germany Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: Germany 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
ITALY
  • Table 44: Italy Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Italy 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 46: Italy Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: Italy 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
UNITED KINGDOM
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 48: UK Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: UK 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 50: UK Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: UK 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
REST OF EUROPE
  • Table 52: Rest of Europe Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Rest of Europe 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 54: Rest of Europe Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Rest of Europe 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
ASIA-PACIFIC
  • Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 58: Asia-Pacific Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: Asia-Pacific 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
REST OF WORLD
  • Table 60: Rest of World Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: Rest of World 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2024 & 2030
  • Table 62: Rest of World Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Rest of World 7-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABcann Medicinals, Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corporation
  • Emerald Health Therapeutics Inc.
  • Green Relief Inc.
  • GW Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Maricann Group, Inc.
  • mCig, Inc.
  • Medical Marijuana, Inc.
  • The Cronos Group Inc.
  • The Supreme Cannabis Company
  • Tilray
  • United Cannabis

Table Information